Menu Back toTOPIC-2-SESSION-8-CONTINUED-Audits-and-Inspections-in-Pharmacovigilance
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Joint MHRA/DIA Excellence in Pharmacovigilance
TOPIC 2 SESSION 8 CONTINUED: Audits and Inspections in Pharmacovigilance
Gaby L. Danan, MD, PhD
- Pharmacovigilance Expert
- GLD, France
- Group Manager, Vigilance, Intelligence and Research Group
- Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Audits and Inspections in Pharmacovigilance - Industry Perspective
- Director Regulatory Compliance
- Janssen Pharmaceutical Research & Development Quality & Compliance, United Kingdom